HIV DART 2000 Program Secretariat Corporate Support Registration
Welcome Abstract Submission
Committee Members
General Information
Important Dates
Meeting Format


This program is sponsored by Northwestern University Medical School Office of Continuing Medical Education.

Conference Focus

The focus of HIV DART 2000 is to assemble clinicians, researchers and basic scientists together to advance our knowledge of the ongoing drug development processes in antiretroviral research. HIV DART 2000 will uniquely blend the areas of biology, chemistry, pharmacology and clinical research to provide the scientific community an increased understanding of the current and future challenges in therapeutics for HIV infection.

Conference Program Highlights

  • Opening session will comprise a presentation by Dr. Anthony Fauci, NIAID, National Institutes of Health on Sunday, December 17, 2000 at 2:00 PM

  • Satellite symposia will follow the Opening Session

  • Scientific sessions commence at 8:00 AM on Monday, December 18, 2000

  • The conference program includes sessions covering the following topics:
  • Drug Design and Discovery: Viral Targets
  • Chemistry and Pre-Clinical Development
  • Viral Resistance
  • Phenotypic and Genotypic Assays
  • Pharmacology
  • Immunotherapy in HIV Infection
  • First-line and Salvage Therapy
  • Treatment Failure and Drug Interactions
  • Pediatrics
  • HIV/Hepatitis and Other Co-infections
  • Vaccines/Therapeutic Vaccines

Important Dates

Conference dates December 17-21, 2000
Early registration deadline September 29, 2000
Abstract submission deadline November 6, 2000
Abstract acceptance notification November 20, 2000
Final date for registration December 4, 2000
Opening session at 2:00 PM December 17, 2000
Scientific sessions begin at 8:00 AM December 18, 2000
Scientific sessions end at 12:30 PM December 21, 2000

|